The ROE as of December 2025 (TTM) for Palvella Therapeutics, Inc. (PVLA) is -73.14%

According to Palvella Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -73.14%. This represents a change of 278.36% compared to the average of -19.33% of the last 4 quarters.

Palvella Therapeutics, Inc. (PVLA) Historical ROE (quarterly & annually)

How has PVLA ROE performed in the past?

The mean historical ROE of Palvella Therapeutics, Inc. over the last ten years is -115.22%. The current -73.14% ROE has changed -36.52% with respect to the historical average. Over the past ten years (40 quarters), PVLA's ROE was at its highest in in the March 2024 quarter at 40.45%. The ROE was at its lowest in in the September 2023 quarter at -35.24%.

Palvella Therapeutics, Inc. (PVLA) ROE by Quarter and Year

Discovering the peaks and valleys of Palvella Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Palvella Therapeutics, Inc. (PVLA) Average ROE

How has PVLA ROE performed in the past?

The current ROE of Palvella Therapeutics, Inc. (PVLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Palvella Therapeutics, Inc. (PVLA) ROE vs. Peers

How is PVLA’s ROE compared to its peers?

Palvella Therapeutics, Inc.’s ROE is greater than GH Research PLC (-16.71%), greater than ARS Pharmaceuticals, Inc. (-38.77%), less than Nanobiotix S.A. (155.77%), less than ProKidney Corp. (11.01%), greater than Savara Inc. (-69.05%), greater than Kura Oncology, Inc. (-65.42%), greater than Arbutus Biopharma Corporation (-50.20%), greater than Rezolute, Inc. (-62.82%), greater than EyePoint Pharmaceuticals, Inc. (-76.13%), greater than Tyra Biosciences, Inc. (-31.80%),

Build a custom stock screener for Palvella Therapeutics, Inc. (PVLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palvella Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Palvella Therapeutics, Inc. (PVLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Palvella Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.